Table 4 Response to treatment related to sCD73 enzyme activity levels
From: Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
sCD73 < 27.8 pmol/min/mg protein | sCD73 > 27.8 pmol/min/mg protein | Pts | |
|---|---|---|---|
CR | – | – | 0 |
PR | 9 (100%) | 0 | 9 |
SD | 8 (100%) | 0 | 8 |
PD | 9 (52.9%) | 8 (47.1%) | 17 |
DCR (CR + PR + SD) | 17 (100%) | 0 | 17 |